Prophylactic indomethacin for preterm infants: A systematic review and meta-analysis

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 6, 2003, Pages

  Fowlie, P W ^b   Davis, P G ^a,c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

BLINDNESS; BRAIN HEMORRHAGE; CEREBRAL PALSY; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DEVELOPMENTAL DISORDER; DIGESTIVE SYSTEM PERFORATION; DISEASE SEVERITY; ENTEROCOLITIS; GASTROINTESTINAL DISEASE; HEARING IMPAIRMENT; HUMAN; INFANT; INFANT DISEASE; INFANT MORTALITY; KIDNEY DISEASE; LUNG DYSPLASIA; LUNG HEMORRHAGE; MEDLINE; META ANALYSIS; MORBIDITY; NEUROLOGIC DISEASE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SENSORY DYSFUNCTION; SENSORY SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0344515374     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.88.6.f464     Document Type: Review

References (21)

1. Fowlie P. Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child 1996;74:F81-7.
2. Fowlie PW. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Library. Issue 2. Oxford: Update Software, 2002.
3. Bandstra ES, Montalvo BM, Goldberg RN, et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988;82:533-42.
4. Couser RJ, Ferrara TB, Wright GB, et al. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr 1996;128:631-7.
5. Gutierrez NG, Lapasset M. Prophylactic indomethacin and the incidence of patent ductus arteriosus in preterm neonates [abstract]. Proceedings of the 3rd Argentinian Congress of Perinatology 1987.
6. Hanigan WC, Kennedy G, Roemisch F, et al. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr 1988;112:941-7.
7. Mahony L, Caldwell RL, Girod DA, et al. Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 1985;106:801-5.
8. Ment LR, Duncan CC, Ehrenkranz RA, et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr 1985;107:937-43.
9. Ment LR, Duncan CC, Ehrenkranz RA, et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr 1988;112:948-55.
10. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93:543-50.
11. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Peadiatr 1994;124:951-5.
12. Schmidt B, Davis P, Moddemann D, et al. Long term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-72.
13. Supapannachart S, Khowsathit P, Patchakapati B. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams. J Med Assoc Thai 1999;82(suppl 1):S87-92.
14. Yaseen H, al Umran K, Ali H, et al. Effects or early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. J Trop Pediatr 1997;43:42-6.
15. Bada HS, Green RS, Pourcyrous M, et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr 1989;115:631-7.
16. Domenico RS, Waldman JD, Lester LA, et al. Prophylactic indomethacin reduce the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant-treated infant <1250 g [abstract]. Pediatr Res 1994;35:331A.
17. Krueger E, Mellander M, Bratton D, et al. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 1987;111:749-54.
18. Morales-Suarez M, Sanchez-Gil T, Lemus-Varela L. Estudio comparavito de dosis baja de indometicina profilactica para hemorragia subependimaria/ intraventricular en neonatos pretermino con ventilation mecanica [Low dose indomethacin for prevention of intraventricular hemorrhage in the preterm infant with mechanical ventilation: Final report of a randomized study]. Bol Med Hosp Infant Mex 1994;51:389-94.
19. Puckett CG, Cox MA, Haskins KS, et al. Prophylactic indomethacin for the prevention of patent ductus arteriosus (PDA). Pediatr Res 1985;19:358.
20. Rennie JM, Doyle J, Cooke RW. Early administration of indomethacin to preterm infants. Arch Dis Child 1986;61:233-8.
21. Vincer M, Allen A, Evans J, et al. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand 1987;76:894-7.